Prospective study of epidemiology and prognostic factors in community-acquired pneumonia

被引:43
作者
Gomez, J
Banos, V
Gomez, JR
Soto, MC
Munoz, L
Nunez, ML
Canteras, M
Valdes, M
机构
[1] UNIV MURCIA, FAC MED, DEPT PATOL & CLIN MED, MURCIA, SPAIN
[2] UNIV MURCIA, FAC MED, DEPT BIOESTADIST, MURCIA, SPAIN
关键词
D O I
10.1007/BF01709363
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Of 342 patients with community-acquired pneumonia, 100 were diagnosed etiologically. In these patients, disease epidemiology, prognostic factors, and influence of antibiotic treatment were analyzed prospectively. Fifty-two patients were treated with a broad-spectrum antibiotic (ceftriaxone), and 48 received a medium-spectrum antibiotic (cefuroxime); some patients in each group also received erythromycin. Streptococcus pneumoniae was the most frequently isolated microorganism (43%), followed by Chlamydia pneumoniae (21%), Haemophilus influenzae (19%), and Mycoplasma pneumoniae (11%). Factors significantly associated with increased mortality were initially critical or poor clinical condition, involvement of two or more lobules, and complications. Prior administration of antibiotics was predictive of penicillin and erythromycin resistance in Streptococcus pneumoniae, but had no effect on the course of the disease. Eight patients died, 89 were cured, and three had recurrences; there! was no significant difference in outcome between treatment groups, regardless of whether patients also received erythromycin. Increased knowledge of epidemiological, predictive, and prognostic factors can significantly improve early diagnosis of community-acquired pneumonia and facilitate the choice of appropriate antibiotic treatment, thereby helping to reduce morbidity and mortality.
引用
收藏
页码:556 / 560
页数:5
相关论文
共 32 条
  • [1] ALMIRALL J, 1993, EUR RESPIR J, V6, P14
  • [2] AMSTERDAM D, 1989, ANTIMICROBIAL NEWSLE, V6, P1
  • [3] ANDREWS BE, 1987, Q J MED, V62, P195
  • [4] PROSPECTIVE-STUDY ON THE ETIOLOGY OF COMMUNITY-ACQUIRED PNEUMONIA IN CHILDREN AND ADULTS IN SPAIN
    AUSINA, V
    COLL, P
    SAMBEAT, M
    PUIG, I
    CONDOM, MJ
    LUQUIN, M
    BALLESTER, F
    PRATS, G
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1988, 7 (03) : 343 - 347
  • [5] GENERAL-GUIDELINES FOR THE CLINICAL-EVALUATION OF ANTIINFECTIVE DRUG PRODUCTS
    BEAM, TR
    GILBERT, DN
    KUNIN, CM
    [J]. CLINICAL INFECTIOUS DISEASES, 1992, 15 : S5 - S32
  • [6] ETIOLOGY OF COMMUNITY ACQUIRED PNEUMONIA IN VALENCIA, SPAIN - A MULTICENTER PROSPECTIVE-STUDY
    BLANQUER, J
    BLANQUER, R
    BORRAS, R
    NAUFFAL, D
    MORALES, P
    MENENDEZ, R
    SUBIAS, I
    HERRERO, L
    REDON, J
    PASCUAL, J
    [J]. THORAX, 1991, 46 (07) : 508 - 511
  • [7] INCIDENCE OF COMMUNITY-ACQUIRED PNEUMONIA CAUSED BY CHLAMYDIA-PNEUMONIAE IN ITALIAN PATIENTS
    BLASI, F
    COSENTINI, R
    LEGNANI, D
    DENTI, F
    ALLEGRA, L
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1993, 12 (09) : 696 - 699
  • [8] DEALBORNOZ MMC, 1991, MED CLIN-BARCELONA, V97, P50
  • [9] BACTERIAL RESPIRATORY-INFECTIONS AND PNEUMONIA
    DORCA, J
    [J]. CURRENT OPINION IN INFECTIOUS DISEASES, 1990, 3 (02) : 176 - 180
  • [10] Dronda F, 1989, Enferm Infecc Microbiol Clin, V7, P312